Purpose This study aims to evaluate the risk factors and prognosis for CMV diseases in
hematologic malignancy patients without hematopoietic stem-cell transplantation (HSCT) …

Background High‐intensity chemotherapy and advances in novel immunotherapies have
seen the emergence of cytomegalovirus (CMV) infections in cancer patients other than …

Background Life-threatening cytomegalovirus infection (CMVI) has been reported even in
patients with malignant lymphoma (ML) who have not received hematopoietic stem cell …

Objectives Patients with hematologic diseases were at high risk for cytomegalovirus (CMV)
diseases. In the present study, we compare various prognostic factors during CMV viremia …

Background CMV infection is a common complication in allogeneic hematopoietic stem cell
transplantation (HSCT). We investigated the association of clinically significant CMV (CS …

It has been shown recently that donor and/or recipient cytomegalovirus (CMV) seropositivity
is associated with a significant overall survival (OS) decline in acute leukemia patients who …

Because of the widespread use of immunosuppressive drugs, CMV infection is one of the
most important causes of morbidity and mortality in patients with haematological …

Cytomegalovirus (CMV) can cause end-organ diseases including pneumonia,
gastroenteritis, retinitis, and encephalitis in hematopoietic stem cell transplantation …

Background Cytomegalovirus (CMV) infection is associated with poor outcome in ICU
patients. However, data on immunocompromised patients are scarce. This study aims to …

Cytomegalovirus (CMV) infection is a frequent complication in immunocompromised
patients with impaired cellular immunity, including recipients of hematopoietic stem cell …